Medical e-learning platform 123sonography annunces launch of adult congenital heart disease bachelorclass

After much demand, the Austrian Medical E-Learning Gigant Releases the Adult Congenital Heart Disease course.

123sonography announced today the launch of Adult Congenital Heart Disease BachelorClass, the company’s 22nd online course. The Adult Congenital Heart Disease BachelorClass is a cohesive course covering the spectrum of common and (more or less) simple congenital defects. The course offers medical professionals a new way to echocardiographically assess congenital defects, including imaging modalities such as MRI and CT.

"Echocardiography in Adult Congenital Heart Disease is a large and complex topic - but the demand is enormous," says Prof. Thomas Binder, founder and Medical Chief Officer of 123sonography. "We decided to produce an online course on this topic, breaking things down to make it easier to understand and providing hundreds of case examples and demonstrations. This is certainly the most extensive online course on this topic."

Features and benefits of the new Adult Congenital Heart Disease BachelorClass include:

  • Over 8+ hours of high-quality video content
  • Imaging and patient demonstrations
  • Hundreds of images and illustrations
  • Case-based learning
  • MCQ questions
  • CME credits (pending)
  • Diploma & Certificates
  • Top speakers (Prof. Thomas Binder MD, Elena Surkova MD, MSC, and Matthias Schneider, MD, MSC)

The Adult Congenital Heart Disease BachelorClass will be available on June 1st. For more information on Adult Congenital Heart Disease BachelorClass, visit Adult-Congenital Heart Disease Bachelorclass.

About 123sonography GmbH: 

123sonography is the global No.1 e-learning platform for medical ultrasound and echocardiography and aims to transform medical education. The commitment to producing high-quality videos through proven didactic methods and enthusiasm for the latest digital technology sets 123sonography apart from traditional education.

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)